The immune checkpoint LILRB4 promotes immune evasion and is correlated with disease progression and secondary malignancies in chronic lymphocytic leukemia.
- DOI
- 10.1016/j.biopha.2025.118253
- Published
- 2025-06-13
- Container
- Biomed Pharmacother
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.biopha.2025.118253,
title = {The immune checkpoint LILRB4 promotes immune evasion and is correlated with disease progression and secondary malignancies in chronic lymphocytic leukemia.},
author = {Sordo-Bahamonde C and Martínez-Pérez A and Granda-Díaz R and Pascual J and Aguilar-García C and González-Rodríguez AP and González-García E and Beltrán DC and Bras LM and Payer ÁR and Lorenzo-Herrero S and Gonzalez S.},
year = {2025},
journal = {Biomed Pharmacother},
doi = {10.1016/j.biopha.2025.118253},
url = {https://doi.org/10.1016/j.biopha.2025.118253}
}RIS
TY - JOUR TI - The immune checkpoint LILRB4 promotes immune evasion and is correlated with disease progression and secondary malignancies in chronic lymphocytic leukemia. AU - Sordo-Bahamonde C AU - Martínez-Pérez A AU - Granda-Díaz R AU - Pascual J AU - Aguilar-García C AU - González-Rodríguez AP AU - González-García E AU - Beltrán DC AU - Bras LM AU - Payer ÁR AU - Lorenzo-Herrero S AU - Gonzalez S. PY - 2025 JO - Biomed Pharmacother DO - 10.1016/j.biopha.2025.118253 UR - https://doi.org/10.1016/j.biopha.2025.118253 ER -
APA
C, S., A, M., R, G., J, P., C, A., AP, G., E, G., DC, B., LM, B., ÁR, P., S, L., & S., G. (2025). The immune checkpoint LILRB4 promotes immune evasion and is correlated with disease progression and secondary malignancies in chronic lymphocytic leukemia.. Biomed Pharmacother. https://doi.org/10.1016/j.biopha.2025.118253
Source records
- europe-pmc · retrieved 2026-09-26T07:00:06.684Z